BAJAJ BROKING

Notification
No new Notification messages
Vishal Mega Mart IPO is Open!
Apply for the Vishal Mega Mart IPO through UPI in just minutes.
Open a Free Demat Account
Pay ZERO maintenance charges for the first year, get free stock picks daily, and more.
Trade Now, Pay Later with up to 4x
Never miss a good trading opportunity due to low funds with our MTF feature.
Track Market Movers Instantly
Stay updated with real-time data. Get insights at your fingertips.
NSE BSE
vijaya diagnostic cen ltd stock

VIJAYA DIAGNOSTIC CEN LTD Share Price

1087.65 -12.25 (-1.11%)
Dec 12 2024 03:30 PM Healthcare NSE: VIJAYA

VIJAYA DIAGNOSTIC CEN LTD Share Price Update

As of the latest trading session, VIJAYA DIAGNOSTIC CEN LTD share price is currently at 1087.65, which is down by -12.25 from its previous closing. Today, the stock has fluctuated between 1067.00 and 1118.15. Over the past year, VIJAYA DIAGNOSTIC CEN LTD has achieved a return of 76.49 %. In the last month alone, the return has been 2.65 %. Read More...

VIJAYA DIAGNOSTIC CEN LTD Performance

Day Range

Low1067.00 High1118.15
1087.65

52 Week Range

Low 596.05 High 1249.95
1087.65

VIJAYA DIAGNOSTIC CEN LTD Share Price

5585

543350

VIJAYA

img img img img
No Data Available

Open Price

1099.00

Prev. Close

1099.90

Volume (Shares)

428897.00

Total traded value

4664.89

Upper Circuit

1319.85

Lower Circuit

879.95

Note: The current prices & values are delayed, Login to your account for live updates.

VIJAYA DIAGNOSTIC CEN LTD Fundamentals


(Standalone)

Market Cap (Cr) 11131.63
PE Ratio (TTM) 90.00
Book Value / Share 69.77
Beta 0.08
ROE 17.17%
EPS (TTM) 12.24
Dividend Yield 0.09%
Net Profit Qtr (Cr) 39.50

VIJAYA DIAGNOSTIC CEN LTD Financials

  • Key Results
  • Key Ratios
  • Balance sheet
  • Cash Flow
  • Competition

Revenue

Net income

Particulars SEP 2024 (Values in Cr)
Revenue 168.61
Operating Expense 119.88
Net Profit 39.50
Net Profit Margin (%) 23.42
Earnings Per Share (EPS) 3.85
EBITDA 74.97
Effective Tax Rate (%) 26.20
Particulars JUN 2024 (Values in Cr)
Revenue 142.42
Operating Expense 107.94
Net Profit 28.86
Net Profit Margin (%) 20.26
Earnings Per Share (EPS) 2.82
EBITDA 59.55
Effective Tax Rate (%) 24.66
Particulars MAR 2024 (Values in Cr)
Revenue 141.05
Operating Expense 104.66
Net Profit 30.51
Net Profit Margin (%) 21.63
Earnings Per Share (EPS) 2.98
EBITDA 60.66
Effective Tax Rate (%) 23.34
Particulars DEC 2023 (Values in Cr)
Revenue 129.12
Operating Expense 98.48
Net Profit 25.25
Net Profit Margin (%) 19.55
Earnings Per Share (EPS) 2.47
EBITDA 54.29
Effective Tax Rate (%) 25.38
Particulars SEP 2023 (Values in Cr)
Revenue 136.13
Operating Expense 99.25
Net Profit 32.85
Net Profit Margin (%) 24.13
Earnings Per Share (EPS) 3.21
EBITDA 63.28
Effective Tax Rate (%) 24.98
Particulars MAR 2024 (Values in Cr)
Revenue 525.02
Operating Expense 391.94
Net Profit 114.60
Net Profit Margin (%) 21.82
Earnings Per Share (EPS) 11.21
EBITDA 231.59
Effective Tax Rate (%) 24.83
Particulars MAR 2023 (Values in Cr)
Revenue 449.58
Operating Expense 352.88
Net Profit 83.23
Net Profit Margin (%) 18.51
Earnings Per Share (EPS) 8.16
EBITDA 193.54
Effective Tax Rate (%) 25.19
Particulars MAR 2022 (Values in Cr)
Revenue 450.88
Operating Expense 319.42
Net Profit 108.10
Net Profit Margin (%) 23.97
Earnings Per Share (EPS) 10.60
EBITDA 212.77
Effective Tax Rate (%) 25.12
Particulars MAR 2021 (Values in Cr)
Revenue 367.32
Operating Expense 268.56
Net Profit 82.82
Net Profit Margin (%) 22.54
Earnings Per Share (EPS) 18.28
EBITDA 174.13
Effective Tax Rate (%) 24.41
Particulars MAR 2020 (Values in Cr)
Revenue 328.65
Operating Expense 258.69
Net Profit 61.24
Net Profit Margin (%) 18.63
Earnings Per Share (EPS) 135.13
EBITDA 144.24
Effective Tax Rate (%) 25.08
Particulars MAR 2024 (Values in Cr)
Book Value / Share 64.21
ROE % 19.91
ROCE % 21.15
Total Debt to Total Equity 0.42
EBITDA Margin 43.75
Particulars MAR 2023 (Values in Cr)
Book Value / Share 53.37
ROE % 16.82
ROCE % 18.43
Total Debt to Total Equity 0.43
EBITDA Margin 42.72
Particulars MAR 2022 (Values in Cr)
Book Value / Share 45.92
ROE % 26.76
ROCE % 28.07
Total Debt to Total Equity 0.39
EBITDA Margin 46.83
Particulars MAR 2021 (Values in Cr)
Book Value / Share 79.22
ROE % 26.87
ROCE % 26.77
Total Debt to Total Equity 0.48
EBITDA Margin 47.20
Particulars MAR 2020 (Values in Cr)
Book Value / Share 605.79
ROE % 25.94
ROCE % 24.58
Total Debt to Total Equity 0.64
EBITDA Margin 43.68
Particulars MAR 2024 (Values in Cr)
Book Value / Share 63.83
ROE % 17.17
ROCE % 18.75
Total Debt to Total Equity 0.42
EBITDA Margin 41.15
Particulars MAR 2023 (Values in Cr)
Book Value / Share 53.40
ROE % 16.40
ROCE % 18.10
Total Debt to Total Equity 0.42
EBITDA Margin 43.05
Particulars MAR 2022 (Values in Cr)
Book Value / Share 46.09
ROE % 26.03
ROCE % 27.59
Total Debt to Total Equity 0.38
EBITDA Margin 47.19
Particulars MAR 2021 (Values in Cr)
Book Value / Share 79.56
ROE % 25.96
ROCE % 26.32
Total Debt to Total Equity 0.46
EBITDA Margin 47.41
Particulars MAR 2020 (Values in Cr)
Book Value / Share 612.32
ROE % 24.82
ROCE % 27.61
Total Debt to Total Equity 0.39
EBITDA Margin 43.89
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 73.07
Total Assets 982.75
Total Liabilities 982.75
Total Equity 659.91
Share Outstanding 102345693
Price to Book Ratio 9.95
Return on Assets (%) 12.09
Return on Capital (%) 18.01
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 116.42
Total Assets 853.40
Total Liabilities 853.40
Total Equity 546.63
Share Outstanding 102071175
Price to Book Ratio 7.33
Return on Assets (%) 9.91
Return on Capital (%) 15.48
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 192.35
Total Assets 713.46
Total Liabilities 713.46
Total Equity 469.54
Share Outstanding 101965926
Price to Book Ratio 9.50
Return on Assets (%) 15.37
Return on Capital (%) 23.33
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 194.24
Total Assets 541.24
Total Liabilities 541.24
Total Equity 359.23
Share Outstanding 45318190
Price to Book Ratio 0.00
Return on Assets (%) 15.60
Return on Capital (%) 23.23
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 118.19
Total Assets 482.25
Total Liabilities 482.25
Total Equity 274.13
Share Outstanding 4531819
Price to Book Ratio 0.00
Return on Assets (%) 12.96
Return on Capital (%) 21.02
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 62.01
Total Assets 962.13
Total Liabilities 962.13
Total Equity 653.32
Share Outstanding 102345693
Price to Book Ratio 9.95
Return on Assets (%) 11.91
Return on Capital (%) 17.54
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 111.42
Total Assets 850.06
Total Liabilities 850.06
Total Equity 545.08
Share Outstanding 102071175
Price to Book Ratio 7.33
Return on Assets (%) 9.79
Return on Capital (%) 15.27
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 186.05
Total Assets 710.83
Total Liabilities 710.83
Total Equity 469.98
Share Outstanding 101965926
Price to Book Ratio 9.50
Return on Assets (%) 15.20
Return on Capital (%) 23
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 188.54
Total Assets 533.15
Total Liabilities 533.15
Total Equity 360.54
Share Outstanding 45318190
Price to Book Ratio 0.00
Return on Assets (%) 15.53
Return on Capital (%) 22.97
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 113.65
Total Assets 475.14
Total Liabilities 475.14
Total Equity 277.49
Share Outstanding 4531819
Price to Book Ratio 0.00
Return on Assets (%) 12.88
Return on Capital (%) 20.67
Particulars MAR 2024 (Values in Cr)
Net Income 158.68
Cash from Operations 217.20
Cash from Investing -142.30
Cash from Financing -44.54
Net change in Cash -3.55
Free Cash Flow 305.16
Particulars MAR 2023 (Values in Cr)
Net Income 113.51
Cash from Operations 190.83
Cash from Investing -109.57
Cash from Financing -41.91
Net change in Cash 13.12
Free Cash Flow 315.67
Particulars MAR 2022 (Values in Cr)
Net Income 147.38
Cash from Operations 197.92
Cash from Investing -123.06
Cash from Financing -30.57
Net change in Cash 4.36
Free Cash Flow 320.27
Particulars MAR 2021 (Values in Cr)
Net Income 112.12
Cash from Operations 160.86
Cash from Investing -129.74
Cash from Financing -48.76
Net change in Cash -48.88
Free Cash Flow 192.99
Particulars MAR 2020 (Values in Cr)
Net Income 83.42
Cash from Operations 129.39
Cash from Investing -30.62
Cash from Financing -29.54
Net change in Cash 45.94
Free Cash Flow 176.94
Particulars MAR 2024 (Values in Cr)
Net Income 152.47
Cash from Operations 208.23
Cash from Investing -139.14
Cash from Financing -43.34
Net change in Cash -7.72
Free Cash Flow 294.15
Particulars MAR 2023 (Values in Cr)
Net Income 111.27
Cash from Operations 188.71
Cash from Investing -108.47
Cash from Financing -41.25
Net change in Cash 12.89
Free Cash Flow 313.16
Particulars MAR 2022 (Values in Cr)
Net Income 144.38
Cash from Operations 194.59
Cash from Investing -126.62
Cash from Financing -24.71
Net change in Cash 4.07
Free Cash Flow 316.69
Particulars MAR 2021 (Values in Cr)
Net Income 109.58
Cash from Operations 159.00
Cash from Investing -128.82
Cash from Financing -48.18
Net change in Cash -49.17
Free Cash Flow 190.95
Particulars MAR 2020 (Values in Cr)
Net Income 81.75
Cash from Operations 131.74
Cash from Investing -34.30
Cash from Financing -28.08
Net change in Cash 46.26
Free Cash Flow 179.06
Company Name Price P/E P/B Market Cap 52 Week Low/High
APOLLO HOSPITALS ENTER. L 7342.30 89.24 14.08 105571.01 5286.00 / 7545.10
FORTIS MALAR HOSPITALS LIMITED 62.99 0.00 3.95 118.05 44.00 / 107.94
SHREE PACETRONIX LTD. 121.20 19.52 3.24 43.62 106.00 / 268.50
TRANSGENE BIOTEK LTD. 7.66 0.00 5.35 58.04 5.79 / 12.46
Company Name Price P/E P/B Market Cap 52 Week Low/High
APOLLO HOSPITALS ENTER. L 7342.30 94.01 12.88 105571.01 5286.00 / 7545.10
Surlux Diagnostic Ltd 1.40 0.84 0.13 0.49 0.00 / 0.00
CHENNAI MEENAKSHI MULTISPECIAL 54.13 0.00 -28.99 40.44 29.25 / 59.90
KOVAI MEDICAL CENTER & HOSPITA 5427.00 29.43 6.09 5937.14 3050.00 / 5770.00

Technicals

  • EMA & SMA
  • Resistance and Support
  • Price Change Analysis
- redarrow -
red-green-graph indicator
Bullish Moving Averages -
Bearish Moving Averages -
  • 5 Days 1120.50
  • 26 Days 1101.30
  • 10 Days 1133.80
  • 50 Days 1050.10
  • 12 Days 1136.40
  • 100 Days 976.60
  • 20 Days 1122.90
  • 200 Days 671.40
1103.65
PIVOT
First Resistance 1114.05
Second Resistance 1128.20
Third Resistance 1138.60
First Support 1089.50
Second Support 1079.10
Third Support 1064.95
RSI 50.61
MACD 35.10
Commodity Channel Index (CCI) -32.15
ADX 59.00
Williams % R -95.76

Over 1 Month

down

2.65

Over 3 Months

down

19.97

Over 6 Months

down

35.84

Over 1 Year

down

76.49

Over 3 Years

down

24.48

Over 5 Years

down

0.00

VIJAYA DIAGNOSTIC CEN LTD Future

Future: Price

25 May
0 100 200 300 400 500 600

Discount/Premium

25 May
0 1 2 3 4 5 6 7

Active Calls

25 May
0 500 1000 1500 2000 2500 3000

Active Puts

25 Jul
0 500 1000 1500 2000 2500

VIJAYA DIAGNOSTIC CEN LTD Shareholding Pattern

  • Shareholding Summary
  • Historical Promotor Holding
  • Historical MF Holding
  • Historical FII Holding

Holding

Public
4.49
Promoter Holdings
53.91
FII
18.13
DII
23.46
Promoter Shares(Pledge Percentage)
0.0
Name Category Shares Shares%
Surendranath Reddy Sura Shareholding of Promoter and Promoter Group 3.3422899E7 32.57
Suprita S Reddy Shareholding of Promoter and Promoter Group 9176933.0 8.94
Sunil Chandra Kondapally Shareholding of Promoter and Promoter Group 8596933.0 8.38
Nippon Life India Trustee Ltd-a/c Nippon India Mul Public Shareholding 6246199.0 6.09
Kotak Small Cap Fund Public Shareholding 5121429.0 4.99
Geetha Reddy Sura Shareholding of Promoter and Promoter Group 4058638.0 3.95
Wasatch Emerging India Fund Public Shareholding 3245700.0 3.16
Axis Mutual Fund Trustee Ltd. A/c Axis Mutual Fund Public Shareholding 3131977.0 3.05
Mirae Asset Great Consumer Fund Public Shareholding 2559147.0 2.49
The India Fund Inc Public Shareholding 1917692.0 1.87
Abrdn Asia Focus Plc Public Shareholding 1809737.0 1.76
Aberdeen New India Investment Trust Plc Public Shareholding 1732382.0 1.69
Birudavolu Vishnu Priya Shareholding of Promoter and Promoter Group 27922.0 0.03
Venkata Sanjay Kumar Puligoru Shareholding of Promoter and Promoter Group 10000.0 0.01
Birudavolu Gautam Shareholding of Promoter and Promoter Group 11136.0 0.01
P Madhulika Shareholding of Promoter and Promoter Group 10000.0 0.01
Vijaya Holdings India Llp Shareholding of Promoter and Promoter Group 0.0 0.0
Manjula Kankanti Shareholding of Promoter and Promoter Group 0.0 0.0
Nanda Kumar Birudavolu Shareholding of Promoter and Promoter Group 0.0 0.0
Birudavolu Charitha Reddy Shareholding of Promoter and Promoter Group 0.0 0.0
Birudavolu Dayakar Reddy Shareholding of Promoter and Promoter Group 5000.0 0.0
Birudavolu Jalaja Shareholding of Promoter and Promoter Group 5000.0 0.0

VIJAYA DIAGNOSTIC CEN LTD

  • Dividend
  • Bonus
  • Split
Ex-Date Dividend Amt. Dividend Type Record Date Instrument Type
2023-09-13 1.0 Final 2023-09-13 Equity shares 2022-09-20 1.0 Final 2022-09-21 Equity shares
Ex-Date Ex-Bonus Ratio
Ex-Date Old FV NEW FV Record Date

Learn More About Stocks

About VIJAYA DIAGNOSTIC CEN LTD

Read More
  • Management structure
  • Board of directors
  • Committees of the board of directors

Companies Owned by VIJAYA DIAGNOSTIC CEN LTD

We have something for everyone

Explore More Investment Options

Stocks

Secure and enhance your financial future today

investment-card-icon

IPOs

Your gateway to future financial opportunities

investment-card-icon

MTF

Explore Buy Now Pay Later and boost your capital by up to 4x  

investment-card-icon

US Stocks

Discover opportunities to invest in elite FAANG stocks

investment-card-icon

Frequently Asked Questions

What is the Share Price of Vijaya Diagnostic Centre Ltd?

Answer Field

The share price of Vijaya Diagnostic Centre Ltd for NSE is ₹ 1087.65 and for BSE is ₹ 1088.15.

What is the Market Cap of Vijaya Diagnostic Centre Ltd?

Answer Field

The market cap of Vijaya Diagnostic Centre Ltd for NSE is ₹ 1,11,31.63 Cr. and for BSE is ₹ 1,11,36.75 Cr. as of now.

What is the 52 Week High and Low of Vijaya Diagnostic Centre Ltd?

Answer Field

The 52 Week High and Low of Vijaya Diagnostic Centre Ltd for NSE is ₹ 1249.95 and ₹ 596.05 and for BSE is ₹ 1250.00 and ₹ 596.05.

How to Buy Vijaya Diagnostic Centre Ltd share?

Answer Field

You can trade in Vijaya Diagnostic Centre Ltd shares with Bajaj Broking by opening a Demat Account.

What is 1 year return for Vijaya Diagnostic Centre Ltd?

Answer Field

The 1 year returns on the stock has been 76.49%.

What is the Current Share Price of Vijaya Diagnostic Centre Ltd?

Answer Field

Vijaya Diagnostic Centre Ltd share price is for NSE ₹ 1087.65 & for BSE ₹ 1088.15 as on Dec 12 2024 03:30 PM.

What is the Market Cap of Vijaya Diagnostic Centre Ltd Share?

Answer Field

The market cap of Vijaya Diagnostic Centre Ltd for NSE ₹ 1,11,31.63 & for BSE ₹ 1,11,36.75 as on Dec 12 2024 03:30 PM.

What is the P/E Ratio of Vijaya Diagnostic Centre Ltd Share?

Answer Field

As on Dec 12 2024 03:30 PM the price-to-earnings (PE) ratio for Vijaya Diagnostic Centre Ltd share is 90.00.

What is the PB ratio of Vijaya Diagnostic Centre Ltd Share?

Answer Field

As on Dec 12 2024 03:30 PM, the price-to-book (PB) ratio for Vijaya Diagnostic Centre Ltd share is 69.77.

How to Buy Vijaya Diagnostic Centre Ltd Share?

Answer Field

You can trade in Vijaya Diagnostic Centre Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Vijaya Diagnostic Centre Ltd Share on Bajaj Broking App?

Answer Field

To buy Vijaya Diagnostic Centre Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Vijaya Diagnostic Centre Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

Our Secure Trading Platforms

Level up your stock market experience: Download the Bajaj Broking App for effortless investing and trading

Bajaj Broking App Download

8 Lacs+ Users

icon-with-text

4.4+ App Rating

icon-with-text

4 Languages

icon-with-text

₹4700+ Cr MTF Book

icon-with-text
loader